Year archive

IMUGENE LIMITED — 2015 filings

All 60 regulatory filings released by IMUGENE LIMITED (IMU) in 2015, sourced directly from the official regulator.

60 Filings

2015 Period

2015 filings (60)

Filing	Released	Lang
Imugene to present at the 2016 Biotech Showcase 2 pages 39.9KB Investor Presentation	2015-12-21	English
Imugene key HER-Vaxx patent granted in Europe 2 pages 45.3KB Regulatory Filings	2015-12-17	English
Director Resignation - Mr. Otto Buttula 1 page 112. Board/Management Information	2015-12-16	English
Novotech appointed Contract Research Organisation 2 pages 49.2KB Regulatory Filings	2015-12-13	English
Change of Director's Interest Notice (PH) 2 pages 142.6KB Director's Dealing	2015-12-13	English
Change of Director's Interest Notice (OB) 2 pages 140.9KB Director's Dealing	2015-12-10	English
Change of Director's Interest Notice (PH) 2 pages 142.9KB Director's Dealing	2015-12-07	English
Change of Director's Interest Notice (OB) 2 pages 140.9KB Director's Dealing	2015-11-29	English
Change of Director's Interest Notice (OB) 2 pages 141.6KB Director's Dealing	2015-11-22	English
Change of Director's Interest Notice (CW) 2 pages 138.3KB Director's Dealing	2015-11-12	English
Change of Director's Interest Notice (OB) 2 pages 138.5KB Director's Dealing	2015-11-12	English
Change of Director's Interest Notice (PH) 2 pages 138.9KB Director's Dealing	2015-11-12	English
Appendix 3B 12 pages 289.6KB Capital/Financing Update	2015-11-08	English
Change of Director's Interest Notice (AH) 3 pages 141.9KB Director's Dealing	2015-11-01	English
Change of Director's Interest Notice (CW) 2 pages 137.1KB Director's Dealing	2015-10-29	English
Change of Director's Interest Notice (OB) 2 pages 137.7KB Director's Dealing	2015-10-29	English
Imugene Receives $755k R&D Tax Refund 1 page 116.9K Capital/Financing Update	2015-10-27	English
Appendix 4C - quarterly 5 pages 143.8KB Interim / Quarterly Report	2015-10-27	English
Ceasing to be a substantial holder 2 pages 153.6KB Major Shareholding Notification	2015-10-27	English
Appendix 3B and Section 708A Notice 14 pages 340.0KB Capital/Financing Update	2015-10-25	English
Appendix 3B - Loyalty Option Issue 12 pages 289.4KB Capital/Financing Update	2015-10-22	English
Prospectus for Placement & Loyalty Options 37 pages 2.5MB Share Issue/Capital Change	2015-10-22	English
Letter to Option Holders 1 page 57.2KB Share Issue/Capital Change	2015-10-22	English
AGM Corporate Presentation 15 pages 6.9MB AGM Information	2015-10-14	English
Results of Meeting 1 page 60.7KB Declaration of Voting Results & Voting Rights Announcements	2015-10-14	English
Imugene announces bonus options issue 1 page 42.0KB Capital/Financing Update	2015-10-12	English
Notice of Annual General Meeting/Proxy Form 27 pages 238.1KB AGM Information	2015-09-13	English
Imugene Announces Successful Capital Raising 2 pages 71.9KB Capital/Financing Update	2015-09-07	English
Corporate Presentation 20 pages 3.8MB Investor Presentation	2015-09-07	English
Trading Halt 2 pages 336.2KB Capital/Financing Update	2015-09-06	English
Appendix 4E and Annual Report 2015 65 pages 1.7MB Annual Report	2015-08-30	English
Appendix 4G 9 pages 83.7KB Governance Information	2015-08-30	English
Summary of Full Year Results 2 pages 58.5KB Annual Report	2015-08-30	English
Immuno-oncology Specialist Appointed Chief Operating Officer 1 Board/Management Information	2015-08-26	English
Appendix 4C - quarterly 5 pages 151.9KB Interim / Quarterly Report	2015-07-29	English
Change of Share Registry 1 page 77.2KB Regulatory Filings	2015-07-23	English
New Research Note available from Edison Investment Research 1 Report Publication Announcement	2015-07-12	English
CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial 2 pages 107.2KB Regulatory Filings	2015-06-30	English
Proposed Issue of Options to Dr Axel Hoos 1 page 60 Capital/Financing Update	2015-06-28	English
Prof Ursula Wiedermann Appointed Chief Scientific Officer 1 Board/Management Information	2015-06-04	English
HER-Vaxx superior to Herceptin in tumour model 5 pages 577.6KB Management Reports	2015-05-21	English
Appendix 4C - quarterly 5 pages 152.1KB Interim / Quarterly Report	2015-04-28	English
Imugene Files New HER-Vaxx Patent 1 page 62.0KB Regulatory Filings	2015-04-20	English
HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold 2 pages 75.8KB Regulatory Filings	2015-04-19	English
News Update and Corporate Presentation 29 pages 13.2MB Investor Presentation	2015-04-19	English
New Research Note available from Edison Investment Research 1 Report Publication Announcement	2015-04-13	English
Investor Presentation 14 pages 10.5MB Investor Presentation	2015-03-23	English
Investor Presentation 18 pages 10.4MB Investor Presentation	2015-03-09	English
Imugene to Present at 27th Annual Roth Conference 1 Regulatory Filings	2015-03-05	English
Summary of Half Year results 2 pages 60.0KB Interim / Quarterly Report	2015-02-26	English
Appendix 4D - Half Yearly Report and Accounts 25 pages 832.7KB Interim / Quarterly Report	2015-02-26	English
Grant of Options to Dr Nick Ede & Appendix 3B 13 pages 402.7KB Share Issue/Capital Change	2015-02-26	English
Response to Price Query 3 pages 222.2KB Regulatory Filings	2015-02-19	English
Imugene Receives $230K Research and Development Tax Refund 1 Capital/Financing Update	2015-02-17	English
Investor Presentation 16 pages 3.1MB Investor Presentation	2015-02-09	English
Appointment of Charles Walker as Managing Director 1 Board/Management Information	2015-02-01	English
Initial Director's Interest Notice 3 pages 102.9KB Director's Dealing	2015-02-01	English
Appendix 4C - quarterly 5 pages 152.6KB Interim / Quarterly Report	2015-01-27	English
Investor Presentation 25 pages 4.2MB Investor Presentation	2015-01-12	English
Appendix 3B 13 pages 385.0KB Regulatory Filings	2015-01-05	English

Filings by year

2026 52 filings
2025 103 filings
2024 70 filings
2023 105 filings
2022 122 filings
2021 150 filings
2020 90 filings
2019 69 filings
2018 66 filings
2017 58 filings
2016 52 filings
2015 60 filings
2014 57 filings
2013 64 filings
2012 41 filings
2011 13 filings
2010 20 filings
2009 17 filings
2008 34 filings
2007 35 filings
2006 29 filings
2005 31 filings
2004 50 filings
2003 40 filings
2002 12 filings